We are live on
!
Find out more
CM
CM Management Portfolio holdings
AUM
$120M
1-Year Est. Return
37.12%
This Fund
S&P 500
This Quarter
Est. Return
-1.99%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$13.3M
(-10%)
Cap. Flow
-$4.3M
Cap. Flow
% of AUM
-3.61%
Top 10 Holdings %
Top 10 Hldgs %
39.21%
Holding
91
New
3
Increased
43
Reduced
6
Closed
20
Top Buys
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.97M |
| 2 |
Kyndryl
KD
|
+$1.35M |
| 3 |
B
Barrick Mining
B
|
+$1.18M |
| 4 |
EXE
Expand Energy Corp
EXE
|
+$1.1M |
| 5 |
Heron Therapeutics
HRTX
|
+$1.1M |
Top Sells
| 1 |
CTRA
Coterra Energy
CTRA
|
+$3.04M |
| 2 |
Kinder Morgan
KMI
|
+$1.98M |
| 3 |
Cytokinetics
CYTK
|
+$1.95M |
| 4 |
First Financial Corp
THFF
|
+$1.81M |
| 5 |
CVS Health
CVS
|
+$1.55M |
Sector Composition
| 1 | Healthcare | 37.33% |
| 2 | Energy | 14.56% |
| 3 | Financials | 10.58% |
| 4 | Materials | 8.62% |
| 5 | Technology | 7.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Plains GP Holdings
PAGP
$5.04B
| $1.73M | 1.45% |
150,000
| – | – |
|
|
NWLI
27
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $1.68M | 1.41% |
8,000
| – | – |
|
28
PTC Therapeutics
PTCT
$6.51B
| $1.49M | 1.25% |
40,000
+5,000
| +14% | +$193K |
|
|
CADE
29
DELISTED
Cadence Bank
CADE
| $1.46M | 1.23% |
50,000
-13,000
| -21% | -$406K |
|
30
Atea Pharmaceuticals
AVIR
$377M
| $1.44M | 1.21% |
200,000
+100,000
| +100% | +$679K |
|
31
Citigroup
C
$221B
| $1.33M | 1.12% |
25,000
+5,000
| +25% | +$309K |
|
|
RNWK
32
DELISTED
RealNetworks Inc
RNWK
| $1.17M | 0.98% |
2,018,629
+568,629
| +39% | +$415K |
|
33
Theravance Biopharma
TBPH
$880M
| $1.15M | 0.96% |
120,000
+70,000
| +140% | +$686K |
|
34
ClearPoint Neuro
CLPT
$452M
| $1.15M | 0.96% |
110,000
+40,000
| +57% | +$364K |
|
|
35
Heron Therapeutics
HRTX
$90.1M
| $1.14M | 0.96% |
200,000
+150,000
| +300% | +$1.1M |
|
36
Preformed Line Products
PLPC
$1.61B
| $1.14M | 0.96% |
18,000
+10,000
| +125% | +$599K |
|
|
TAST
37
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $1.13M | 0.95% |
500,000
+100,000
| +25% | +$257K |
|
38
Cytosorbents Corp
CTSO
$23.2M
| $1.12M | 0.94% |
350,000
+50,000
| +17% | +$179K |
|
|
AE
39
DELISTED
Adams Resources & Energy Inc
AE
| $1.11M | 0.94% |
28,950
| – | – |
|
|
PRTK
40
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $1.04M | 0.87% |
350,000
+50,000
| +17% | +$188K |
|
41
OneSpan
OSPN
$576M
| $1.01M | 0.85% |
70,000
| – | – |
|
42
Tejon Ranch
TRC
$504M
| $1M | 0.84% |
55,000
| – | – |
|
|
NEUE
43
DELISTED
NeueHealth
NEUE
| $965K | 0.81% |
6,250
+2,500
| +67% | +$555K |
|
44
Elicio Therapeutics
ELTX
$84M
| $954K | 0.8% |
45,000
+33,822
| +303% | +$764K |
|
45
Bristow Group
VTOL
$1.31B
| $927K | 0.78% |
25,000
-7,000
| -22% | -$240K |
|
46
American Superconductor
AMSC
$1.6B
| $913K | 0.77% |
120,000
+40,000
| +50% | +$342K |
|
47
Eledon Pharmaceuticals
ELDN
$296M
| $887K | 0.74% |
225,000
+110,000
| +96% | +$426K |
|
|
MCLD
48
DELISTED
mCloud Technologies Corp. Common Shares
MCLD
| $843K | 0.71% |
195,166
| – | – |
|
49
Pan American Silver
PAAS
$17.7B
| $819K | 0.69% |
30,000
+5,000
| +20% | +$123K |
|
50
Viatris
VTRS
$20.2B
| $816K | 0.69% |
75,000
-75,000
| -50% | -$988K |
|
Similar funds
AA
CC
DG
ACM
WAG
YMRC
IW
BCWM
CM Management's Q1 2022 Portfolio in Review
As of Q1 2022, CM Management held 91 positions worth $119M, down 10% from $132M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
CM Management withdrew a net $4.3M in Q1 2022, closing 20 positions and reducing 6 holdings. Its most notable exit was Coterra Energy, an estimated $3.04M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 38% a quarter earlier, followed by Energy and Financials.
Against the trend, CM Management opened a new position in Walgreens Boots Alliance worth $1.79M.
- CM Management's largest Q1 2022 buy was Walgreens Boots Alliance: 40,000 shares worth $1.79M.
- CM Management added most to Kyndryl in Q1 2022, an estimated $1.35M increase.
- CM Management's biggest Q1 2022 reduction was Cytokinetics, cutting an estimated $1.95M.
- CM Management fully exited Coterra Energy in Q1 2022, selling an estimated $3.04M.
- CM Management's ten largest holdings make up 39% of its $119M portfolio in Q1 2022.
- CM Management opened 3 new positions and closed 20 in Q1 2022.
- CM Management's portfolio value fell 10% quarter-over-quarter to $119M.
Based on CM Management's 13F filing for Q1 2022, filed 9 May 2022.